AstraZeneca: Coronary Artery Disease trials
The registry lists 25 Coronary Artery Disease studies with AstraZeneca as lead sponsor. 1 are open to participants now and 11 have results posted.
Phase 1 8Phase 2 5Phase 3 7Phase 4 2No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Tezspire Cardiac Events PASSRecruitingNCT06951867
- AZD5718 Phase IIa Study to Evaluate Efficacy, Safety and Tolerability of Oral AZD5718 in Patients With Coronary Artery Disease (CAD).CompletedNCT03317002Phase 2Results posted
- To Evaluate Safety, Pharmacokinetics and Pharmacodynamics of MEDI6012 in Subjects With Stable Coronary Artery DiseaseCompletedNCT02601560Phase 2Results posted
- A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes MellitusCompletedNCT01991795Phase 3Results posted
- A Pharmacodynamic Study With Ticagrelor in African American PatientsCompletedNCT01523392Phase 4Results posted
- A Pharmacodynamic Study With Ticagrelor in Hispanic PatientsCompletedNCT01523366Phase 4Results posted
- Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS)CompletedNCT01294462Phase 3Results posted
- An Asian Study to Assess the Properties and Profile of Ticagrelor in Patients With Stable Coronary Artery DiseaseCompletedNCT01118325Phase 2Results posted
- A Study of the Antiplatelet Effects Comparing Ticagrelor (Ticag. - AZD6140) With Clopidogrel (Clop.) Responder and Non-respondersCompletedNCT00642811Phase 2Results posted
- CRESTOR Athero Imaging Head to Head IVUS StudyCompletedNCT00620542Phase 3Results posted
- A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With AspirinCompletedNCT00528411Phase 2Results posted
- A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary SyndromeCompletedNCT00391872Phase 3Results posted
- A Study to Assess the Amount of Drug Levels in Blood and Safety of AZD5718 Formulations in Healthy VolunteersCompletedNCT04210388Phase 1
- A Study to Assess the Drug Absorption Into the Blood After Administration of 3 Doses of AZD5718CompletedNCT04087187Phase 1
- Study Evaluating the Pharmacokinetic and Mass Balance of Single Dose [14C] AZD5718 in VolunteersCompletedNCT03948451Phase 1
- A Study to Assess the Bioavailability of Different Formulations of AZD5718 and the Food Effect on the Selected Formulation of AZD5718 in Healthy VolunteersCompletedNCT03420092Phase 1
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Japanese MenCompletedNCT03400488Phase 1
- A Study to Estimate the Effect of AZD5718 on the Pharmacokinetics (What Does the Body Does to the Drug) of Rosuvastatin to Measure the Relative Bioavailability (the Extent to Which a Drug or Other Substance Becomes Available to the Body) of AZD5718 Oral Suspension vs AZD5718 Immediate Release TabletCompletedNCT02963116Phase 1
- Effect of ACP-501 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Subjects With Coronary Artery DiseaseCompletedNCT01554800Phase 1
- Lipid-lowering Therapy for Secondary Prevention in Patients Undergoing Elective Percutaneous Coronary Intervention (PCI)TerminatedNCT01190072
- Study Evaluating How Patients With Acute Coronary Syndrome Are Managed During 2 Years After DischargeCompletedNCT01171404
- Uric Acid Study in Healthy Male VolunteersCompletedNCT00738842Phase 1
- Evaluation of Effects of Rosuvastatin 40mg on Myocardial Ischemia in Subjects With Coronary Artery DiseaseCompletedNCT00657527Phase 3
- A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID)CompletedNCT00240318Phase 3
- Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)CompletedNCT00088179Phase 3